journal
Journals Gastroenterology Clinics of No...

Gastroenterology Clinics of North America

https://read.qxmd.com/read/36813434/gastrointestinal-hepatic-and-pancreatic-manifestations-of-covid-19-infection
#1
EDITORIAL
Mitchell S Cappell
No abstract text is available yet for this article.
March 2023: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36813433/dedication
#2
EDITORIAL
Mitchell S Cappell
No abstract text is available yet for this article.
March 2023: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36813432/gastrointestinal-bleeding-in-covid-19-infected-patients
#3
REVIEW
Mitchell S Cappell, David M Friedel
COVID-19 infection is an ongoing catastrophic global pandemic with significant morbidity and mortality that affects most of the world population. Respiratory manifestations predominate and largely determine patient prognosis, but gastrointestinal (GI) manifestations also frequently contribute to patient morbidity and occasionally affect mortality. GI bleeding is usually noted after hospital admission and is often one aspect of this multisystem infectious disease. Although the theoretical risk of contracting COVID-19 from GI endoscopy performed on COVID-19-infected patients remains, the actual risk does not seem to be high...
March 2023: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36813431/diarrhea-and-coronavirus-disease-2019-infection
#4
REVIEW
David M Friedel, Mitchell S Cappell
The global coronavirus disease-2019 (COVID-19) pandemic has caused significant morbidity and mortality, thoroughly affected daily living, and caused severe economic disruption throughout the world. Pulmonary symptoms predominate and account for most of the associated morbidity and mortality. However, extrapulmonary manifestations are common in COVID-19 infections, including gastrointestinal (GI) symptoms, such as diarrhea. Diarrhea affects approximately 10% to 20% of COVID-19 patients. Diarrhea can occasionally be the presenting and only COVID-19 symptom...
March 2023: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36813430/a-surgical-perspective-of-gastrointestinal-manifestations-and-complications-of-covid-19-infection
#5
REVIEW
Anthony Gebran, Ander Dorken-Gallastegi, Haytham M A Kaafarani
The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2, has quickly spread over the world since December 2019. COVID-19 is a systemic disease that can affect various organs throughout the body. Gastrointestinal (GI) symptoms have been reported in 16% to 33% of all patients with COVID-19 and in 75% of critically ill patients. This chapter reviews the GI manifestations of COVID-19 as well as their diagnostic and treatment modalities.
March 2023: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36813429/the-pancreas-in-coronavirus-disease-2019-infection
#6
REVIEW
Tiago Correia de Sá, Mónica Rocha
An association between acute pancreatitis (AP) and coronavirus disease 2019 (COVID-19) has been proposed but the mechanisms of pancreatic injury of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and the implicative role on the development of AP are not yet fully understood. COVID-19 also imposed major challenges on pancreatic cancer management. We conducted an analysis on the mechanisms of pancreatic injury by SARS-CoV-2 and reviewed published case reports of AP attributed to COVID-19. We also examined the pandemic effect on pancreatic cancer diagnosis and management, including pancreatic surgery...
March 2023: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36813428/a-critical-review-from-the-perspective-of-2-years-thereafter-of-the-effectiveness-of-revolutionary-changes-in-a-gastroenterology-division-at-a-medical-school-teaching-hospital-due-to-the-coronavirus-disease-2019-pandemic-gastrointestinal-physician-clinical
#7
REVIEW
Mitchell S Cappell
AIM: Critically review approximately 2 years afterward the effectiveness of revolutionary changes at an academic gastroenterology division from coronavirus disease-2019 (COVID-19) pandemic surge at the metropolitan Detroit epicenter from 0 infected patients on March 9, 2020, to >300 infected patients (one-quarter of) in-hospital census in April 2020 and >200 infected patients in April 2021. SETTING: GI Division, William Beaumont Hospital which had 36 GI clinical faculty who used to perform >23,000 endoscopies annually with a massive plunge in endoscopy volume during the past 2 years; fully accredited GI fellowship since 1973; employs >400 house staff annually since 1995; predominantly voluntary attendings; and primary teaching hospital, Oakland-University-Medical-School...
March 2023: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36813427/critical-review-two-years-thereafter-of-the-effectiveness-of-the-revolutionary-changes-in-a-gastroenterology-division-at-a-medical-school-teaching-hospital-in-response-to-the-covid-19-pandemic-medical-school-residency-and-gastrointestinal-fellowship-education
#8
REVIEW
Mitchell S Cappell
Profound and pervasive GI divisional changes maximized clinical resources devoted to COVID-19-infected patients and minimized risks of transmitting infection. Academic changes degraded by massive cost-cutting while offering institution to about 100 hospital systems and eventually "selling" institution to Spectrum Health, without faculty input.
March 2023: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36813426/pathologic-characteristics-of-digestive-tract-and-liver-in-patients-with-coronavirus-disease-2019
#9
REVIEW
Chunxiu Yang, Lijun Cai, Shu-Yuan Xiao
With the high prevalence of coronavirus disease-2019 (COVID-19), there has been increasing understanding of the pathologic changes associated with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This review summarizes the pathologic changes in the digestive system and liver associated with COVID-19, including the injuries induced by SARS-CoV2 infection of GI epithelial cells and the systemic immune responses. The common digestive manifestations associated with COVID-19 include anorexia, nausea, vomiting, and diarrhea; the clearance of the viruses in COVID-19 patients with digestive symptoms is usually delayed...
March 2023: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36813425/diagnostic-and-therapeutic-radiology-of-the-gi-tract-liver-and-pancreas-in-patients-with-covid
#10
REVIEW
Piero Boraschi, Francescamaria Donati, Ilaria Ambrosini, Luciana Bruni, Maria Letizia Mazzeo, Rachele Tintori, Michele Tonerini, Emanuele Neri
Coronavirus disease 2019 (COVID-19) pulmonary involvement has been extensively reported in the literature. Current data highlight how COVID-19 is a systemic disease, affecting many other organs, including the gastrointestinal, hepatobiliary, and pancreatic organs. Recently, these organs have been investigated using imaging modalities of ultrasound and particularly computed tomography. Radiological findings of the gastrointestinal, hepatic, and pancreatic involvement in patients with COVID-19 are generally nonspecific but are nonetheless helpful to evaluate and manage COVID-19 patients with involvement of these organs...
March 2023: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36813424/surgical-implications-of-coronavirus-disease-19
#11
REVIEW
Ander Dorken-Gallastegi, Dias Argandykov, Anthony Gebran, Haytham M A Kaafarani
As the coronavirus disease-19 (COVID-19) pandemic continues to evolve in 2022 with the surge of novel viral variants, it is important for physicians to understand and appreciate the surgical implications of the pandemic. This review provides an overview of the implications of the ongoing COVID-19 pandemic on surgical care and provides recommendations for perioperative management. Most observational studies suggest a higher risk for patients undergoing surgery with COVID-19 compared with risk-adjusted non-COVID-19 patients...
March 2023: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36813423/gastrointestinal-endoscopy-in-patients-with-coronavirus-disease-2019-indications-findings-and-safety
#12
REVIEW
Shahnaz Sultan
The coronavirus disease 2019 (COVID-19) pandemic has changed the practice of gastroenterology and how we perform endoscopy. As with any new or emerging pathogen, early in the pandemic, there was limited evidence and understanding of disease transmission, limited testing capability, and resource constraints, especially availability of personal protective equipment (PPE). As the COVID-19 pandemic progressed, enhanced protocols with particular emphasis on assessing the risk status of patients and proper use of PPE have been incorporated into routine patient care...
March 2023: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36813422/gastrointestinal-and-hepatobiliary-symptoms-and-disorders-with-long-chronic-covid-infection
#13
REVIEW
Anam Rizvi, Yonatan Ziv, James M Crawford, Arvind J Trindade
Long COVID is a novel syndrome characterizing new or persistent symptoms weeks after COVID-19 infection and involving multiple organ systems. This review summarizes the gastrointestinal and hepatobiliary sequelae of long COVID syndrome. It describes potential biomolecular mechanisms, prevalence, preventative measures, potential therapies, and health care and economic impact of long COVID syndrome, particularly of its gastrointestinal (GI) and hepatobiliary manifestations.
March 2023: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36813421/liver-and-biliary-tract-disease-in-patients-with-coronavirus-disease-2019-infection
#14
REVIEW
Sirina Ekpanyapong, K Rajender Reddy
Coronavirus disease-2019 (COVID-19) had become a global pandemic since March 2020. Although, the most common presentation is of pulmonary involvement, hepatic abnormalities can be encountered in up to 50% of infected individuals, which may be associated with disease severity, and the mechanism of liver injury is thought to be multifactorial. Guidelines for management in patients with chronic liver disease during COVID-19 era are being regularly updated. Patients with chronic liver disease and cirrhosis, including liver transplant candidates and liver transplant recipients are strongly recommended to receive SARS-CoV-2 vaccination because it can reduce rate of COVID-19 infection, COVID-19-related hospitalization, and mortality...
March 2023: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36813420/the-impact-of-covid-19-infection-on-miscellaneous-inflammatory-disorders-of-the-gastrointestinal-tract
#15
REVIEW
Mitchell S Cappell, Martin Tobi, David M Friedel
The novel coronavirus pandemic of COVID-19 has emerged as a highly significant recent threat to global health with about 600,000,000 known infections and more than 6,450,000 deaths worldwide since its emergence in late 2019. COVID-19 symptoms are predominantly respiratory, with mortality largely related to pulmonary manifestations, but the virus also potentially infects all parts of the gastrointestinal tract with related symptoms and manifestations that affect patient treatment and outcome. COVID-19 can directly infect the gastrointestinal tract because of the presence of widespread angiotensin-converting enzyme 2 receptors in the stomach and small intestine that can cause local COVID-19 infection and associated inflammation...
March 2023: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36813419/covid-19-and-inflammatory-bowel-disease
#16
REVIEW
Keith C Summa, Stephen B Hanauer
The COVID-19 pandemic caused by the SARS-CoV-2 virus represents an unprecedented global health crisis. Safe and effective vaccines were rapidly developed and deployed that reduced COVID-19-related severe disease, hospitalization, and death. Patients with inflammatory bowel disease are not at increased risk of severe disease or death from COVID-19, and data from large cohorts of patients with inflammatory bowel disease demonstrate that COVID-19 vaccination is safe and effective. Ongoing research is clarifying the long-term impact of SARS-CoV-2 infection on patients with inflammatory bowel disease, long-term immune responses to COVID-19 vaccination, and optimal timing for repeated COVID-19 vaccination doses...
March 2023: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36813418/the-pathogenesis-of-gastrointestinal-hepatic-and-pancreatic-injury-in-acute-and-long-coronavirus-disease-2019-infection
#17
REVIEW
Hadar Meringer, Andrew Wang, Saurabh Mehandru
The gastrointestinal (GI) tract is targeted by severe acute respiratory syndrome coronavirus-2. The present review examines GI involvement in patients with long coronavirus disease and discusses the underlying pathophysiological mechanisms that include viral persistence, mucosal and systemic immune dysregulation, microbial dysbiosis, insulin resistance, and metabolic abnormalities. Due to the complex and potentially multifactorial nature of this syndrome, rigorous clinical definitions and pathophysiology-based therapeutic approaches are warranted...
March 2023: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36376004/the-three-faces-of-psychogastroenterology-science-practice-and-the-patient
#18
EDITORIAL
Laurie Keefer
No abstract text is available yet for this article.
December 2022: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36376003/foreword
#19
EDITORIAL
Alan L Buchman
No abstract text is available yet for this article.
December 2022: Gastroenterology Clinics of North America
https://read.qxmd.com/read/36376002/sociocultural-considerations-for-food-related-quality-of-life-in-inflammatory-bowel-disease
#20
REVIEW
Tina Aswani-Omprakash, Neha D Shah
The prevalence of inflammatory bowel disease (IBD) is increasing substantially in non-White races and ethnicities in the United States. As a part of promoting quality of life in patients with IBD, the optimization of food-related quality of life (FRQoL) is also indicated. It is known that the practices of food avoidance and restrictive eating are associated with a reduced FRQoL in IBD. Gaining insight into sociocultural influences on FRQoL will aid in the provision of culturally competent interventions to improve FRQoL in patients with IBD...
December 2022: Gastroenterology Clinics of North America
journal
journal
29543
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.